1. Home
  2. HNVR vs UNCY Comparison

HNVR vs UNCY Comparison

Compare HNVR & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hanover Bancorp Inc.

HNVR

Hanover Bancorp Inc.

HOLD

Current Price

$23.23

Market Cap

153.5M

Sector

Finance

ML Signal

HOLD

Logo Unicycive Therapeutics Inc.

UNCY

Unicycive Therapeutics Inc.

HOLD

Current Price

$8.01

Market Cap

145.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HNVR
UNCY
Founded
2008
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Commercial Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
153.5M
145.3M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
HNVR
UNCY
Price
$23.23
$8.01
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$24.50
$25.67
AVG Volume (30 Days)
9.3K
526.3K
Earning Date
04-27-2026
05-13-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
N/A
EPS
0.25
N/A
Revenue
N/A
$675,000.00
Revenue This Year
$35.49
N/A
Revenue Next Year
$8.61
$582.86
P/E Ratio
$23.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.91
$0.47
52 Week High
$24.49
$8.34

Technical Indicators

Market Signals
Indicator
HNVR
UNCY
Relative Strength Index (RSI) 55.80 63.04
Support Level $22.93 $5.95
Resistance Level $24.38 N/A
Average True Range (ATR) 0.42 0.39
MACD -0.02 0.05
Stochastic Oscillator 41.86 71.87

Price Performance

Historical Comparison
HNVR
UNCY

About HNVR Hanover Bancorp Inc.

Hanover Bancorp Inc is a community commercial bank focused on providing personalized and efficient services and products tailored to local needs. The Bank offers a full range of financial services, including a complete suite of consumer, commercial, and municipal banking products such as multifamily and commercial mortgages, government-guaranteed loans, residential loans, business loans, and lines of credit. In addition, it provides customers with access to 24-hour ATM services with no fees, interest-bearing free checking accounts, telephone banking, mobile and internet banking solutions for both consumer and business clients, and safe deposit boxes.

About UNCY Unicycive Therapeutics Inc.

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.

Share on Social Networks: